Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Nov 02, 2023

Jubilant Ingrevia Q2 Results Review - Weathering Challenging Times: Prabhudas Lilladher

Specialty chemical and nutrition and health solutions margins at 16%/9%, however chemical Intermediates business continues to drag

Jubilant Ingrevia Q2 Results Review - Weathering Challenging Times: Prabhudas Lilladher
Chemical solutions in a lab. (Source: Chokniti Khongchum/ pexels)
STOCKS IN THIS STORY
Jubilant Ingrevia Ltd
--

BQ Prime's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BQ Prime's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Prabhudas Lilladher Report

We reduce our FY24/25E earnings per share estimates of Jubilant Ingrevia Ltd. by +15% and cut our SOTP based target price to Rs 433 (earlier Rs 462 to factor-

  1. headwinds on global agro chemicals (generics) along with resultant margin pressure across segments and

  2. spreads normalisation in chemical Intermediates.

Jubilant Ingrevia consolidated revenue declined 22% YoY/ 5% QoQ to Rs 10.2 billion (our estimate Rs 10.7 billion) largely led by chemical intermediates revenue decline on lower raw material prices (key raw material Acetic acid prices down 40% YoY).

Ebitda declined 23% YoY/ +1% QoQ to Rs 1.2 billion (our estimate: 1.1 billion) and Ebitda margin came at 11.5% (versus 11.7% YoY/ 10.9% QoQ).

Profit after tax declined 31% YoY/ 1% QoQ to Rs 574 million (our estimate: Rs 500 million), impacted by lower operating profit YoY and higher interest expense.

We believe, FY24E to be muted due to some demand concerns, yet we are positive on long term growth prospects given healthy volume recovery in nutrition and health solutions segment coupled with improved prices and strong traction in contract development and manufacturing organisation to aid absorption of new capacities.

The stock trades at 24 times P/E at earnings per share of Rs 17.6. Reiterate ‘Hold' rating.

Click on the attachment to read the full report: 

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source